Sunitinib selectively targets leukemogenic signaling of mutant SHP2 in juvenile myelomonocytic leukemia. He C, Peng Z, Zhang D, Guo Y, et al. Biochem Pharmacol 2023;213:115588.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

He C, Peng Z, Zhang D, Guo Y, et al. Sunitinib selectively targets leukemogenic signaling of mutant SHP2 in juvenile myelomonocytic leukemia. Biochem Pharmacol 2023;213:115588.
PMID: 37187274